Dr. Reddys Lab trades in pink of its health on BSE

09 Dec 2014 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 3345.65, up by 30.85 points or 0.93 % from its previous closing of Rs. 3314.80 on the BSE.

The scrip opened at Rs. 3329.80 and has touched a high and low of Rs. 3379.20 and Rs. 3322.00 respectively. So far 8417 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3662.00 on 01-Dec-2014 and a 52 week low of Rs. 2250.00 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 3614.40 and Rs. 3305.00 respectively. The current market cap of the company is Rs. 56987.37 crore.

The promoters holding in the company stood at 25.49 % while Institutions and Non-Institutions held 43.79 % and 13.69 % respectively.

In a recent inspection at Dr Reddy’s Laboratories’ manufacturing plant, the US Food and Drug Administration (FDA) found nine possible procedural deviations and in this context has sought an explanation from the drug maker. These observations largely relate to procedural and other compliances of the plant systems.

With this, the company is in the process of responding the agency within stipulated timeline, sketching down its remedial plans and necessary measures to fix the problem immediately. There were no implications on any activity at the plant and production continued in the normal course.

The plant, which manufactures active pharmaceutical ingredients and bulk drugs and is located Srikakulam district of Andhra Pradesh, was visited by the US Food and Drug Administration last week and in an investors’ judgment these observations were listed on an FDA Form ‘483’. However, according to the company, 483 observations are unlikely to affect the production of the company and therefore, it will continue as per normal routine.

Dr. Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×